阿莫西林
幽门螺杆菌
肽聚糖
微生物学
生物
病菌
抗生素耐药性
抗药性
最小抑制浓度
基因
聚合酶链反应
细菌
医学
遗传学
抗生素
卡加
消化性溃疡
细菌遗传学
突变
抗菌剂
病毒学
后天抵抗
作者
Xiaoqiong Tang,Jianping Ying,Yalin Shen,Xiaona Song,Alfred Tay,Mohammed Benghezal,Barry J. Marshall,Hong Tang,Rui Bao,Hong Li
标识
DOI:10.1093/infdis/jiaf516
摘要
Abstract Helicobacter pylori remains a major gastric pathogen associated with chronic gastritis, peptic ulcer disease, and gastric carcinoma worldwide. Although amoxicillin is a cornerstone of H. pylori eradication regimens, rising resistance rates are undermining treatment efficacy. The molecular mechanisms underlying amoxicillin resistance in Southwest China remain incompletely characterized. In this study, we analyzed 1153 H. pylori isolates obtained from 2181 patients, randomly selecting 23 amoxicillin-resistant and 38 susceptible strains for whole-genome sequencing. Antimicrobial susceptibility testing revealed an overall resistance prevalence of 8.3% (minimum inhibitory concentration range: 0.016–32 µg/mL). Notably, amino acid substitutions in the pbp1a gene, specifically N562Y/H and S414R/N, along with novel variants E406K and G597S/A, were significantly enriched in amoxicillin-resistant strains. Furthermore, the number of mutations was positively correlated with the minimum inhibitory concentration. Proteomic analysis following amoxicillin exposure revealed 39 differentially expressed proteins, including those involved in peptidoglycan repair, nickel uptake, and central metabolism. This comprehensive genomic and proteomic study elucidates the mutational spectrum and adaptive protein responses that drive amoxicillin resistance in H. pylori in Southwestern China. These findings provide potential biomarkers for resistance surveillance and offer insights into targeted therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI